Sinohealth Technology Holdings Limited (SINOHEALTH HLDG, 02361) reported that as of 5 March 2026, its public float stands at 16.45%. This level falls below the 25% threshold set under Rule 13.32B(1) of the Listing Rules. The shortfall arises primarily because 39.96 million shares, accounting for 8.84% of the total issued share capital of 451.77 million shares, are held under a share award scheme by a trustee and are not counted toward the public float.
According to the announcement, major shareholders collectively hold 181.24 million shares (40.12%), 20.25 million shares (4.48%), 67.50 million shares (14.94%), and 68.51 million shares (15.17%) respectively. Public shareholders hold 74.31 million shares (16.45%), while the trustee holds the remaining 39.96 million shares (8.84%) not included in the float calculation.
To address the shortfall, Sinohealth Technology Holdings Limited plans to complete granting its share awards over the next three years, aiming to grant no less than 2% of its total issued shares each year to non-core connected persons. Additionally, the entity intends to explore equity financing to expand its share capital or coordinate with major shareholders for partial sell-downs. The announcement states an objective to raise the public float by at least eight percentage points by the end of June 2027, with the goal of reaching the 25% requirement by that time.
Further monthly updates on the public float status will be provided until the prescribed threshold under the Listing Rules is satisfied. Shareholders and potential investors are advised to exercise caution when dealing in the shares.
Comments